文献速递甲状腺疾病

TBX1通过抑制PI3K/AKT和MAPK/ERK通路活性在甲状腺癌中发挥抑癌作用

TBX1 Functions as a Tumor Suppressor in Thyroid Cancer Through Inhibiting the Activities of the PI3K/AKT and MAPK/ERK Pathways.
PubMed 文献 · Thyroid · 2019-02-15

本研究探讨TBX1在甲状腺癌中的作用及机制,发现TBX1在乳头状甲状腺癌和甲状腺癌细胞系中因启动子甲基化而频繁下调。过表达TBX1可抑制细胞活力、集落形成和裸鼠致瘤能力,诱导细胞周期阻滞和凋亡,并抑制迁移侵袭;机制上通过下调RNF41、PARK2、PHLPP2等靶点抑制AKT Ser473和ERK磷酸化。

要点

  • TBX1在乳头状甲状腺癌中因启动子甲基化频繁下调,提示其抑癌功能失活。
  • 过表达TBX1抑制甲状腺癌细胞增殖、迁移侵袭并诱导凋亡,敲低则相反。
  • TBX1通过调控RNF41、PARK2、PHLPP2抑制PI3K/AKT和MAPK/ERK通路。

核心结论

  • TBX1在甲状腺癌中因启动子甲基化频繁失活,作为潜在抑癌基因通过抑制PI3K/AKT和MAPK/ERK通路活性发挥作用。

研究设计与样本

  • 基础研究:采用定量RT-PCR和Western blot评估基因表达,甲基化特异性PCR和焦磷酸测序分析TBX1启动子甲基化。
  • 通过一系列体外和体内实验确定TBX1在甲状腺癌细胞中的生物学功能。
  • 采用染色质免疫共沉淀测序和双荧光素酶报告基因实验鉴定下游靶点。

主要发现

  • TBX1在乳头状甲状腺癌和甲状腺癌细胞系中因启动子甲基化而频繁下调。
  • 甲状腺癌细胞中过表达TBX1显著抑制细胞活力、集落形成和裸鼠致瘤能力,并通过调控细胞周期和凋亡相关基因诱导细胞周期阻滞和凋亡。
  • 过表达TBX1通过抑制上皮-间质转化过程和基质金属蛋白酶表达,显著降低甲状腺癌细胞的迁移和侵袭潜能。
  • 敲低TBX1明显促进甲状腺癌细胞活力和侵袭性。
  • TBX1通过调控RNF41、PARK2和PHLPP2等下游靶点,抑制AKT Ser473和ERK的磷酸化。

临床怎么用

  • TBX1启动子甲基化可作为甲状腺癌抑癌基因失活的潜在分子标志,但其临床应用价值尚需进一步验证。
  • 恢复TBX1功能或靶向其下游PI3K/AKT和MAPK/ERK通路可能成为甲状腺癌的潜在治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: TBX1 is a member of the T-box family of transcription factors characterized by a conserved DNA binding domain termed T-box. TBX1 has been reported to be downregulated in mouse skin tumors and is considered a negative regulator of tumor cell growth in mice. However, its role and exact mechanism in human cancers, including thyroid cancer, remain totally unknown. METHODS: Quantitative reverse transcription polymerase chain reaction and Western blot assays were performed to evaluate the expression of investigated genes. Methylation-specific polymerase chain reaction and pyrosequencing were used to analyze TBX1 promoter methylation. The biological functions of TBX1 in thyroid cancer cells were determined by a series of in vitro and in vivo experiments. Chromatin immunoprecipitation sequencing and dual-luciferase reporter assays were used to identify its downstream targets. RESULTS: This study demonstrates that TBX1 is frequently downregulated by promoter methylation in both papillary thyroid cancers and thyroid cancer cell lines. Ectopic expression of TBX1 in thyroid cancer cells dramatically inhibits cell viability, colony formation, and tumorigenic potential in nude mice, and induces cell-cycle arrest and apoptosis through modulating a panel of cell-cycle and apoptosis-related genes. In addition, ectopic expression of TBX1 significantly decreases the migration and invasion potential of thyroid cancer cells through inhibiting the process of epithelial-mesenchymal transition and the expression of matrix metalloproteinases. On the other hand, TBX1 knockdown markedly promotes thyroid cancer cell viability and invasiveness. Mechanistically, TBX1 exerts its tumor suppressor function in thyroid cancer cells through inhibiting phosphorylation of AKT at Ser473 and ERK via regulating its downstream targets such as RNF41, PARK2, and PHLPP2. CONCLUSIONS: The data show that TBX1 is frequently inactivated by promoter methylation and functions as a potential tumor suppressor in thyroid cancer through inhibiting the activities of the PI3K/AKT and MAPK/ERK signaling pathways.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Wang N, Li Y, Wei J, et al. TBX1 Functions as a Tumor Suppressor in Thyroid Cancer Through Inhibiting the Activities of the PI3K/AKT and MAPK/ERK Pathways. Thyroid. 2019. PMID: 30543152. doi:10.1089/thy.2018.0312

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。